An R75W mutation in the gap junction β2 (GJB2) gene causes severe fragmentation of gap junction plaques, connecting adjacent ...
16h
News-Medical.Net on MSNTransforming genetic deafness treatment with base editingCongenital hearing loss refers to impaired auditory function that occurs due to genetic causes. GJB2 is the gene responsible ...
The field of gene editing recently got a major boost from Massachusetts-based Beam Therapeutics, and the company’s Durham ...
A comprehensive approach, including robust preclinical research and a streamlined regulatory process, is the key ...
The patient died of acute liver failure; the maker of the gene therapy noted that the patient also had a recent ...
R75W mutation in the gap junction β2 (GJB2) gene causes severe fragmentation of gap junction plaques, connecting adjacent ...
Drug regulator through executive order issued last August paved way for direct launch of certain categories of drugs approved ...
ViroCell Biologics ("ViroCell" or the "Company"), a cell and gene therapy ("CGT") contract development and manufacturing organization ("CDMO") specializing in GMP viral vector manufacturing for ...
Mahidol University is undergoing a strategic transformation to strengthen its position as a world-class leader in health ...
The biotechnology sector is gaining new momentum with better market conditions, cutting-edge innovations, and growing ...
Deloitte urged pharma executives to “be bold” in a new report tracking the top 20 pharmaceutical companies’ R&D performance.
20h
Clinical Trials Arena on MSNEpicrispr secures $68m for facioscapulohumeral muscular dystrophy therapy trialEpicrispr has raised $68m in the initial close of its Series B financing round to commence the clinical trial of EPI-321 for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results